PATENT CLAIM ANALYSIS

Application Number: 16117020
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["514", "263210"]

Abstract:
The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Claim (Index 8):
A method for alleviating a symptom associated with multiple system atrophy, comprising administering to a subject an effective amount of a-compound, 1-(2-isopropoxyethyI)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidin-4-one, or a pharmaceutically acceptable salt thereof, wherein the administration can provide a mean daily motor score in MSA mice of less than about 5.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 2.42857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13465691', '15454318', '14951979', '12295306', '11720913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7068532073298635
- 35 USC 102 Novelty (BERT): 0.5084968319318213
- Combined Prediction Score: 0.6870175697900593
- Mean Citation Score: 207.860734
- Max Citation Score: 214.44319
- Similarity Product: 134.34601494989454

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test